Medication-related adverse events in health care—what have we learned? A narrative overview of the current knowledge O. LaatikainenS. SneckM. Turpeinen Review Open access 06 October 2021 Pages: 159 - 170
Maternal non-steroidal anti-inflammatory drug exposure during pregnancy and risk of miscarriage: a systematic review and meta-analysis Xian-hua YingDan-ni BaoYu-dan Shi Review 11 October 2021 Pages: 171 - 180
Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis Guangyan MuHanxu ZhangYimin Cui Review 15 October 2021 Pages: 181 - 190
Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial Lisa SödermanMåns EdlundLena Marions Clinical Trial Open access 20 October 2021 Pages: 191 - 196
Comparative analysis of PIM criteria and drug labels in the elderly Yanwen WangXiaohe LiWei Liu Pharmacodynamics 04 January 2022 Pages: 197 - 204
Effect of gene polymorphism on bleeding complications in Chinese Han patients taking warfarin Xiaotong XiaJinglan FuJinhua Zhang Pharmacogenetics 01 October 2021 Pages: 205 - 214
Utility of a pharmacogenetic-driven algorithm in guiding dual antiplatelet therapy for patients undergoing coronary drug-eluting stent implantation in China Si-qi LyuJun ZhuYan-min Yang Pharmacogenetics 12 October 2021 Pages: 215 - 225
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case–control study Iveta MerćepIvana RadmanNada Božina Pharmacogenetics 19 October 2021 Pages: 227 - 236
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients T. PreijersM. W. F. van SpenglerR. A. A. Mathôt Pharmacokinetics and Disposition Open access 15 October 2021 Pages: 237 - 249
Population pharmacokinetics of cefotaxime in intensive care patients Maria SwartlingAnna-Karin SmekalElisabet I. Nielsen Pharmacokinetics and Disposition Open access 01 October 2021 Pages: 251 - 258
Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ9-tetrahydrocannabinol: a pilot study Erica N. PetersLaura MacNairMarcel O. Bonn-Miller Pharmacokinetics and Disposition Open access 18 October 2021 Pages: 259 - 265
Drug-related deaths among inpatients: a meta-analysis Tejas K. PatelParvati B. PatelSurekha Kishore Pharmacoepidemiology and Prescription 18 October 2021 Pages: 267 - 278
Investigation of the risk factors of vomiting during linezolid therapy: a retrospective observational study Takezo TsutsumiShungo ImaiYoh Takekuma Pharmacoepidemiology and Prescription 28 September 2021 Pages: 279 - 286
Bevacizumab and aflibercept in second-line metastatic colorectal cancer: 12 years of experience Raquel Claramunt GarcíaCarmen Lucía Muñoz CidJuan Francisco Marín Pozo Pharmacoepidemiology and Prescription 18 October 2021 Pages: 287 - 291
Feasibility and usability of a mobile health tool on anticoagulation management for patients with atrial fibrillation: a pilot study Chi ZhangMang-Mang PanHou-Wen Lin Pharmacoepidemiology and Prescription 20 October 2021 Pages: 293 - 304
Mega randomized clinical trials: a definitive solution or a double-edged sword? Florian LemaitreBruno Laviolle Point of View 14 October 2021 Pages: 305 - 306
Association between the use of hormonal contraceptives and risk of gallstone disease Shih-Wei LaiChiu-Shong LiuBing-Fang Hwang Letter to the Editor 09 October 2021 Pages: 307 - 308
Response to letter regarding the article “Association between the use of hormonal contraceptives and risk of cholecystectomy in women of reproductive age” Farzin Khosrow-KhavarMohit SodhiMahyar Etminan Letter to the Editor 06 October 2021 Pages: 309 - 310
